LUNG Overview

Earnings Performance: Pulmonx Corporation reported a quarterly loss of $0.34 per share, better than the expected loss of $0.40, marking a 15% earnings surprise. The company has surpassed consensus EPS estimates in all four recent quarters.

Revenue Growth: The company generated revenues of $21.5 million for the quarter, exceeding the Zacks Consensus Estimate by 4.1% and showing an increase from $20.39 million a year ago.

Stock Outlook: Despite underperforming the market with a 69.2% decline in shares this year, Pulmonx holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. Future stock movements will depend on earnings estimate revisions.

Industry Context: The Medical Info Systems industry, where Pulmonx operates, is currently ranked in the top 20% of Zacks industries, suggesting a favorable environment for stocks in this sector.

Analyst Downgrades: Jefferies downgraded Ramaco Resources from Buy to Hold, lowering the price target from $45 to $33, while Chardan Capital downgraded Avidity Biosciences from Buy to Neutral, reducing the target from $75 to $72.

Price Target Adjustments: Morgan Stanley cut F5 Inc's target from $352 to $336 but maintained an Equal-Weight rating, while RBC Capital lowered Intellia Therapeutics' target from $21 to $14, downgrading it from Outperform to Sector Perform.

Analyst Upgrades: Clear Street upgraded Core Scientific from Hold to Buy, raising the price target from $14 to $23, and Morgan Stanley increased Nucor Corp's target from $152 to $165, keeping an Overweight rating.

Mixed Ratings: Barclays raised Cadence Bank's target from $46 to $47 but downgraded the stock from Overweight to Equal-Weight, reflecting a cautious outlook despite the price increase.

Celestica's Strong Performance: Celestica Inc. reported better-than-expected Q3 earnings of $1.58 per share and revenue of $3.19 billion, leading to an 8.3% increase in its stock price during pre-market trading.

Notable Gainers: Several stocks saw significant pre-market gains, including TEN Holdings (up 89.2%), Freight Technologies (up 65.1%), and Reliance Global Group (up 48%) after completing a purchase and announcing a dividend.

Major Losers: Co-Diagnostics experienced a 13.5% drop in pre-market trading following a previous surge, while Rambus Inc. fell 14.3% after disappointing quarterly earnings.

Market Overview: The article highlights various stocks moving in pre-market trading, showcasing both significant gainers and losers, reflecting the volatility and reactions to recent company announcements.